13F

Stock

Supernus Pharmaceuticals, Inc.

SUPN · held by 2 managers

Reported value

$305.1K

Holders

2

+0 new · −0 exited

Holders’ est. mark

$29.8K

Price effect on 2 books still in the name

Largest holder

$288.3K

Henshaw Capital LLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
Henshaw Capital LLC8.92K$288.3K$28.2KAdded$28.2K
Leonteq Securities AG520$16.8K$1.64KAdded$1.64K

Positions as of Q1 2022. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.